The American Cancer Society (ACS) has announced a new editor-in-chief and editor to lead its flagship journal CA: A Cancer Journal for Clinicians, which publishes the latest information about the prevention, early detection, and treatment of cancer, as well as nutrition, palliative care, survivorship, and additional topics of interest related to cancer care. Dr. Arif Kamal, chief patient officer at the American Cancer Society, assumed the role of editor-in-chief of CA in late 2022. Dr. Don Dizon, a researcher and professor of medicine and surgery at Brown University, joins the journal as the new editor. He will assume the role on April 1, 2023, when current editor, Dr. Ted Gansler, retires after more than twenty-three years at the journal.
In addition to his position at ACS, Dr. Kamal is an oncologist, researcher, professor, and innovative leader at Duke University and the Duke Cancer Institute. He is nationally recognized as an expert in oncology quality assessment and palliative care and has published more than 200 peer-reviewed articles in leading medical journals.
Dr. Dizon is the director of the pelvic malignancies program and hematology-oncology outpatient clinics at the Lifespan Cancer Institute, head of community outreach and engagement at the Legorreta Cancer Center, and director of medical oncology at Rhode Island Hospital. Nationally, he is the vice chair for diversity, equity, inclusion, and professional integrity at the Southwest Oncology Group or SWOG Cancer Research Network. He also is a founding member of the collaboration for outcomes using social media in oncology.
Click here to read the original press release.
